Related Experiment Video
Updated: Jun 16, 2025

Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells
Published on: February 24, 2014
Drug-induced mismatch repair deficiency: Mixed prospects
Ye He1, Hao-Xiang Wu2, Feng Wang1
1Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University, Guangzhou, China; Research Unit of Precision Diagnosis and Treatment for Gastrointestinal Cancer, Chinese Academy of Medical Sciences, Guangzhou, China.
Abstract:
Most metastatic colorectal cancer (CRC) is mismatch repair proficient (pMMR) with low immunogenicity. In this issue of Cancer Cell, Vitiello et al. and Rousseau et al. reveal that temozolomide-cisplatin combinations induce mismatch repair-deficient-like phenotypes and reshape the tumor microenvironment in preclinical pMMR CRC models, yet the clinical trial calls for further optimization.
Related Concept Videos
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Long-patch Base Excision Repair
Base Excision Repair
The first step of...
Overview of DNA Repair
Chemically...
Fixing Double-strand Breaks

